Latest revenue
$403.6M
as of 2026-04-04
Latest net income
$57.1M
as of 2026-04-04
Net margin
14.1%
as of 2026-04-04
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $9.36B
- Enterprise value
- $9.36B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $179.00
- 52-wk low
- $125.94
- Beta
- —
- Shares out
- 52.4M
5-year trend
About MASI
Business description and risk factors will appear here once MASI's latest filing is fully ingested.
Profitability
Gross margin
61.9%
29.1%Operating margin
20.3%
259.4%Net margin
-9.9%
31.8%Return on equity
-21.0%
27.5%Return on assets
-8.9%
23.2%Leverage
Debt / equity
1.36×
9.4%Long-term debt / equity
0.72×
3.8%Debt / assets
57.5%
4.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q2 2026 2026-04-04 | $403.6M | +8.5% | $57.1M | +133.5% | 14.1% |
Q1 2026 2026-01-03 | $412.5M | -61.4% | $68.3M | +119.5% | 16.6% |
Q3 2025 2025-09-27 | $371.5M | +8.2% | $-100.4M | -1124.5% | -27.0% |
Q2 2025 2025-06-28 | $370.9M | +7.9% | $51.3M | +220.6% | 13.8% |
Q1 2025 2025-03-29 | $372.0M | +9.5% | $-170.7M | -1003.2% | -45.9% |
Q4 2024 2024-12-28 | $1.07B | — | $-349.6M | — | -32.7% |
Q3 2024 2024-09-28 | $343.3M | -28.3% | $9.8M | -7.5% | 2.9% |
Q2 2024 2024-06-29 | $343.9M | -24.5% | $16.0M | +1.9% | 4.7% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Electromedical & Electrotherapeutic Apparatus · SIC 3845
Your notes
Keep private notes on MASI — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$468.5K
Insider selling
$4.4M
Net activity
−$3.9M
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns MASI
Institutional value
$2.99B
Total shares held
17.8M
Distinct holders
256
-132 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.6M | $826.1M | -4.2M (-47.6%) | Trimmed |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $364.6M | — | New |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.0M | $357.0M | — | New |
| 4 | JPMORGAN CHASE & CO | 572.6K | $101.5M | +454.8K (+386.1%) | Added |
| 5 | CITIGROUP INC | 533.4K | $94.9M | +412.2K (+340.0%) | Added |
| 6 | HSBC HOLDINGS PLC | 473.4K | $84.3M | — | New |
| 7 | UBS Group AG | 468.3K | $83.3M | -131.0K (-21.9%) | Trimmed |
| 8 | Liontrust Investment Partners LLP | 627.8K | $81.7M | +0 (+0.0%) | No change |
| 9 | Magnetar Financial LLC | 427.1K | $76.0M | +421.6K (+7729.2%) | Added |
| 10 | Capital Research Global Investors | 359.1K | $63.9M | -278.8K (-43.7%) | Trimmed |
| 11 | WESTFIELD CAPITAL MANAGEMENT CO LP | 341.2K | $60.7M | -1.2M (-77.6%) | Trimmed |
| 12 | Hudson Bay Capital Management LP | 330.7K | $58.8M | — | New |
| 13 | Bank of New York Mellon Corp | 306.4K | $54.5M | -2.1K (-0.7%) | Trimmed |
| 14 | VANGUARD FIDUCIARY TRUST CO | 289.9K | $51.6M | — | New |
| 15 | NUANCE INVESTMENTS, LLC | 244.7K | $43.5M | — | New |
| 16 | MUFG Securities EMEA plc | 225.4K | $40.1M | — | New |
| 17 | Erste Asset Management GmbH | 200.0K | $35.5M | +0 (+0.0%) | No change |
| 18 | ALPINE ASSOCIATES MANAGEMENT INC. | 189.0K | $33.6M | — | New |
| 19 | DIMENSIONAL FUND ADVISORS LP | 164.4K | $29.2M | -9.5K (-5.5%) | Trimmed |
| 20 | Champlain Investment Partners, LLC | 141.3K | $25.1M | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once MASI's latest filing finishes processing.